Further, we demonstrated that ELOVL5-mediated PUFA elongation enhanced the lipid raft-associated AKT-mTOR signaling activation that may contribute to the enzalutamide resistance of PCa. The gene discussed is ELOVL5; the disease is posterior cortical atrophy.